Published in Clin Pharmacol Ther on July 20, 2011
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci (2014) 0.95
The fraction dose absorbed, in humans, and high jejunal human permeability relationship. Mol Pharm (2012) 0.86
Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine. AAPS J (2013) 0.78
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Des Devel Ther (2014) 0.78
BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements. AAPS J (2016) 0.77
Quantitation of small intestinal permeability during normal human drug absorption. BMC Pharmacol Toxicol (2013) 0.77
In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs. Colomb Med (Cali) (2015) 0.75
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res (1995) 12.09
Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res (2005) 4.13
A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm (2006) 2.07
The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm (2008) 1.86
Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res (2002) 1.74
White paper on the therapeutic equivalence of chemically equivalent drugs. JAMA (1969) 1.43
What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metab Rev (2007) 1.42
Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res (2001) 1.39
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res (2002) 1.37
Intestinal permeability and its relevance for absorption and elimination. Xenobiotica (2007) 1.26
The use of drug metabolism for prediction of intestinal permeability (dagger). Mol Pharm (2009) 1.23
Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership. Mol Pharm (2007) 1.22
The FDA should eliminate the ambiguities in the current BCS biowaiver guidance and make public the drugs for which BCS biowaivers have been granted. Clin Pharmacol Ther (2010) 1.15
Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J Pharm Sci (2008) 1.04
High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations. Mol Pharm (2010) 0.99
Application of method suitability for drug permeability classification. AAPS J (2010) 0.93
Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Bull Hist Med (2008) 0.85
Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States. J Pharmacokinet Biopharm (1974) 0.84
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res (1995) 12.09
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 6.73
Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell (1999) 4.83
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20
Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09
Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (1997) 4.07
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem (2000) 3.49
Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med (1998) 3.11
Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med (1986) 2.87
Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int (2006) 2.85
GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A (1999) 2.80
Studies on cytochrome oxidase. Interactions of the cytochrome oxidase protein with phospholipids and cytochrome c. J Biol Chem (1975) 2.80
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol (1994) 2.70
X-ray diffraction of actively shortening muscle. Proc Natl Acad Sci U S A (1976) 2.59
Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol (1993) 2.54
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res (1997) 2.28
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun (2008) 2.15
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm (2000) 2.14
Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom (1991) 2.10
Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res (1998) 2.08
Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol (2000) 2.06
Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res (1996) 2.05
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02
Linker histones are not essential and affect chromatin condensation in vivo. Cell (1995) 1.99
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Hydrogenase measurement with photochemically reduced methyl viologen. J Bacteriol (1969) 1.85
Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med Phys (2009) 1.85
Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol (2008) 1.84
Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 1.68
5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (1998) 1.66
KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene (2010) 1.65
Inhibitor binding changes domain mobility in the iron-sulfur protein of the mitochondrial bc1 complex from bovine heart. Proc Natl Acad Sci U S A (1998) 1.65
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Tumor necrosis factor alpha in children with sickle cell disease in stable condition. J Natl Med Assoc (1997) 1.63
Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J (2002) 1.63
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun (1999) 1.62
Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem (1998) 1.61
Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res (1997) 1.60
Biology's new Rosetta stone. Nature (1997) 1.59
The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development (1999) 1.59
Comparison between permeability coefficients in rat and human jejunum. Pharm Res (1996) 1.59
Occult lumbar lateral spinal stenosis in neural foramina subjected to physiologic loading. AJNR Am J Neuroradiol (1996) 1.58
Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes (1995) 1.55
Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med (2000) 1.55
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene (2011) 1.54
Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice. Gene Ther (2012) 1.53
ICA512 autoantibody radioassay. Diabetes (1995) 1.52
Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health (1999) 1.52
Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem (2000) 1.51
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia (2001) 1.49
Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Eur J Surg Oncol (2010) 1.49
Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int (2007) 1.49
Fano resonance for Anderson impurity systems. Phys Rev Lett (2004) 1.48
Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care (1999) 1.47
Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA (1986) 1.45
T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience (2004) 1.45
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci (2000) 1.45
Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature (1993) 1.44
The circulatory responses to fibreoptic intubation: a comparison of oral and nasal routes. Anaesthesia (2006) 1.44
Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. Eur J Neurol (2011) 1.42
The mechanical effectiveness of erect and "bent-hip, bent-knee" bipedal walking in Australopithecus afarensis. J Hum Evol (1998) 1.41
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci (2004) 1.41
Selected chitinase genes in cultured and uncultured marine bacteria in the alpha- and gamma-subclasses of the proteobacteria. Appl Environ Microbiol (2000) 1.41
Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain (2012) 1.40
Cardiogenic shock with takotsubo-like cardiomyopathy in functional retroperitoneal paraganglioma. Herz (2014) 1.38
Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates. J Am Chem Soc (2001) 1.37
Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem (1998) 1.37
Masking of Bacillus megaterium KM membrane reduced nicotinamide adenine dinucleotide oxidase and solubilization studies. J Bacteriol (1970) 1.36
Targeted prodrug design to optimize drug delivery. AAPS PharmSci (2000) 1.36
A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm (1999) 1.35
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia (2009) 1.34
Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J (1993) 1.34
Divalent cation activation of deoxycholate-solubilized and -inactivated membrane reduced nicotinamide adenine dinucleotide oxidase of Bacillus megaterium KM. J Bacteriol (1970) 1.33
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques (1996) 1.28
Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab (2006) 1.27
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene (2011) 1.27
Function and organization of photosystem I in a cyanobacterial mutant strain that lacks PsaF and PsaJ subunits. J Biol Chem (1994) 1.27
Kinetics of electron transfer between cardiac cytochrome c 1 and c. J Biol Chem (1973) 1.26
Mouse muscle nicotinic acetylcholine receptor gamma subunit: cDNA sequence and gene expression. Nucleic Acids Res (1986) 1.24
RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci U S A (1996) 1.23
Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions. Biochemistry (1998) 1.23
The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem (1994) 1.23
Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett (1994) 1.23
Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology (1988) 1.23
Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci U S A (1995) 1.23
Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel. J Biol Chem (1994) 1.22
Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci (1985) 1.21
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem (1998) 1.21
Genotyping of Toxoplasma gondii isolates from cats in different geographic regions of China. Vet Parasitol (2011) 1.20